Skip to Primary Navigation

Skip to main content

DOJ strikes twice over False Claims Act allegations and cybersecurity lapses

Image is of the Illumina corporate headquarters and signage.
Photo: Justin Sullivan/Getty Images

Julie DiMauro

3 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

Failing to meet cybersecurity standards and offering misleading statements about meeting them can lead to penalties for government contractors.

The US Department of Justice (DOJ) has announced a $9.8m settlement with Illumina, known for its work in DNA sequencing and other technologies, citing allegations that the company sold genomic-sequencing systems with software vulnerabilities to federal agencies for multiple years.

The case against the biotech company specializing in

, , , , , ,